Core Points - Liansheng Chemical (301212.SZ) received a warning letter from the Zhejiang Securities Regulatory Bureau due to violations related to the management and use of raised funds [1][2] - The company was found to have purchased financial products with idle raised funds before the authorization period and exceeded the authorized amount [1] - The special reports on the use of raised funds for the first half of 2023, the full year of 2023, the first half of 2024, and the full year of 2024 contained inaccurate disclosures regarding the purchase of large time deposits [1] Regulatory Violations - The company's actions violated the "Regulatory Requirements for the Management and Use of Raised Funds by Listed Companies" and the "Administrative Measures for Information Disclosure of Listed Companies" [2] - Key executives, including the chairman, general manager, former financial director, and board secretary, were held primarily responsible for the violations [2] - The Zhejiang Securities Regulatory Bureau decided to issue warning letters to the company and the related personnel, which will be recorded in the integrity archives of the securities and futures market [2]
联盛化学及相关人员收到浙江证监局警示函